Chargement en cours...
Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) represent the most common subtype of NETs. The incidence of all NETs, and specifically GEP NETs, has risen exponentially over the last three decades. Only within the past several years have these tumors been appropriately classified, allowing...
Enregistré dans:
| Publié dans: | Ther Adv Med Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141991/ https://ncbi.nlm.nih.gov/pubmed/34093744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211018047 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|